RosaiJ. Rosai and Ackerman's Surgical Pathology.9th ed.St Louis, MO: C V Mosby;2004.
8.
FuscoA, ChiappettaG, HuiP. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol.2002; 160: 2157–2167.
9.
WilliamsED. Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol.2003; 8: 181–183.
10.
CastroP, RebochoAP, SoaresRJ. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab.2006; 91: 213–220.
11.
CastroP, FonsecaE, MagalhaesJ, Sobrinho-SimoesM. Follicular, papillary, and “hybrid” carcinomas of the thyroid. Endocr Pathol.2002; 13: 313–320.
12.
LloydRV, EricksonLA, CaseyMB. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol.2004; 28: 1336–1340.
13.
RosaíJ, ZampiG, CarcangiuML. Papillary carcinoma of the thyroid: a discussion of its several morphologic expressions, with particular emphasis on the follicular variant. Am J Surg Pathol.1983; 7: 809–817.
14.
BalochZW, LiVolsiVA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol.2000; 13: 861–865.
15.
IvanovaR, SoaresP, CastroP, Sobrinho-SimõesM. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch.2002; 440: 418–424.
16.
NeslandJM, Sobrinho-SimõesMA, HolmR, SambadeMC, JohannessenJV. Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol.1985; 8: 269–290.
17.
Sobrinho-SimõesMA, NeslandJM, HolmR, SambadeMC, JohannessenJV. Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immu-nocytochemical study. Ultrastruct Pathol.1985; 8: 131–142.
TroviscoV, Vieira de CastroI, SoaresP. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol.2004; 202: 247–251.
22.
TrimboliP, UlisseS, GrazianoFM. Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid.2006; 16: 1151–1155.
23.
RosaiJ, LiVolsiVA, Sobrinho-SimoesM, WilliamsED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003; 11: 249-251.
24.
AsioliS, OdassoC, MacrìL, PalestiniN, BussolatiG. Merits of the PMiT (papillary microtumor) terminology in the definition of a subset of incidental papillary microcarcinomas of the thyroid. Int J Surg Pathol.2009; 17: 378–383.
25.
VolanteM, ColliniP, NikiforovYE. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol.2007; 31: 1256–1264.
26.
NikiforovaMN, KimuraET, GandhiM. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab.2003; 88: 5399–5404.
27.
SoaresP, TroviscoV, RochaAS. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch.2004; 444: 572–576.
